PRODUCT LITERATURE

CHInese Medicine NeuroAiD Efficacy on Stroke Recovery – Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy

---

The CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) study was an international randomized double-blind placebo-controlled trial of MLC601 (NeuroAiD) in subjects with cerebral infarction of intermedi-ate severity within 72 h. CHIMES-E (Extension) aimed at evaluating the effects of the initial 3-month treatment with MLC601 on long-term outcome for up to 2 years.
Methods: All subjects randomized in CHIMES were eligible for CHIMESE. Inclusion criteria for CHIMES were age ≥ 18, baseline National
Institute of Health Stroke Scale of 6–14, and pre-stroke modified Rankin Scale (mRS) ≤ 1. Initial CHIMES treatment allocation
blinding was maintained, although no further study treatment was provided in CHIMES-E.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

NeuroAid
Acute stroke
Traditional Chinese medicine

Specific Detail Info

-

Statement of Responsibility

Cerebrovasc Dis 2015;39:309–318

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment